Mazdutide Research Information
GLP-1 / Glucagon Dual Receptor Agonist
For Metabolic & Weight Management Research
⚠️ Important: This information is for educational and research purposes only. Always consult with a qualified healthcare professional before use.
📑 Contents
🔬 What is Mazdutide?
Mazdutide (IBI362) is a synthetic dual agonist of the glucagon-like peptide-1 (GLP-1) and glucagon receptors that is being investigated for the treatment of obesity and type 2 diabetes. It is a 39-amino acid peptide with modifications that allow once-weekly dosing .
By activating both GLP-1 and glucagon receptors, mazdutide offers a distinct mechanism of action that combines appetite suppression with increased energy expenditure . Mazdutide is available in pen and freeze-dried vial formulations for research purposes.
⚡ How Mazdutide Works
Mazdutide works through dual receptor activation:
GLP-1 Receptor
Reduces appetite, slows gastric emptying, enhances insulin secretion
Glucagon Receptor
Increases energy expenditure and fat metabolism
Combined, these mechanisms promote reduced food intake, increased calorie burning, and improved glycemic control.
📋 Research Applications
Weight Management
Evaluated for weight reduction in individuals with obesity or overweight
Type 2 Diabetes
Assessed for glycemic control and metabolic improvements
Liver Health
Investigating effects on metabolic dysfunction-associated steatotic liver disease (MASLD)
Cardiometabolic Research
Studying effects on cardiovascular risk factors
📊 Clinical Studies
Phase 2 Clinical Trial (2025)
- Mazdutide demonstrated significant weight reduction in patients with obesity at doses of 4-6 mg once weekly
- Significant reductions in HbA1c, fasting glucose, and liver fat content
- Favorable safety profile with gastrointestinal side effects being the most common
Key Research Findings
- Mazdutide is a dual GLP-1/glucagon receptor agonist
- Demonstrates synergistic effects on weight loss and glycemic control
- Once-weekly dosing with favorable pharmacokinetics
💉 Interactive Dosing Guide
Select your vial size and dose to see the corresponding volume, clicks, dosing frequency, and how many doses per vial:
🖊️ Step 1: Select Your Vial Size
💊 Step 2: Select Your Dose
Common research protocols: 0.5-6 mg once weekly
Vial Size
5mg Vial
Selected Dose
2 mg
Doses per Vial
2.5 doses
Pen Clicks
120 clicks
Volume
1.20 mL
Protocol Level
Level 2 (Standard)
Recommended Schedule
Once weekly - Clinical Protocol
⚠️ Do not change your dose unless advised by a qualified professional.
📋 Protocol Level Summary
Based on research protocols: 0.5-6 mg once weekly.
| Protocol Level | Target Dose | Frequency | 5mg Clicks | 10mg Clicks | 20mg Clicks | Who It\'s For |
|---|---|---|---|---|---|---|
| Level 1 (Starting) | 0.5-1 mg | Once weekly | 30-60 clicks | 15-30 clicks | 7.5-15 clicks | New users, first 4 weeks |
| Level 2 (Standard) | 2-3 mg | Once weekly | 120-180 clicks | 60-90 clicks | 30-45 clicks | After 4 weeks, maintenance |
| Level 3 (Advanced) | 4 mg | Once weekly | 240 clicks | 120 clicks | 60 clicks | If more response needed |
| Level 4 (Maximum) | 6 mg | Once weekly | 360 clicks | 180 clicks | 90 clicks | Experienced users only |
⚠️ Do not change your dose unless advised by a qualified professional.
💉 Vial Users (Insulin Syringe)
Add 3mL of bacteriostatic water to your freeze-dried vial and mix gently. After reconstitution, use the table below to draw your dose:
Vial Size
5mg vial with 3mL bac water
| Dose | Frequency | Units on Syringe | Volume (mL) | Protocol Level |
|---|
⚠️ Always use a new sterile needle and syringe for each injection.
⚠️ Safety & Precautions
Mazdutide has shown a manageable safety profile in clinical studies. The most common adverse events are gastrointestinal side effects, including nausea, vomiting, and diarrhea, which are typically mild-to-moderate and transient.
Do not use if you:
- Are allergic to mazdutide or any ingredients
- Are pregnant or breastfeeding
- Have type 1 diabetes
⚠️ Warning: If you experience severe allergic reactions, difficulty breathing, or signs of anaphylaxis, seek immediate medical help.
📚 References
- Mazdutide Research Overview. Peptide Sciences.
- Mazdutide Technical Guide. Benchchem.
- Mazdutide: A Dual GLP-1/Glucagon Receptor Agonist. Journal of Peptide Research.
This information is for educational and research purposes only. Always consult with a qualified healthcare professional.
Last updated: July 2026